{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T07:34:00Z","timestamp":1792481640001,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004366","name":"Tabriz University of Medical Sciences","doi-asserted-by":"publisher","award":["68036"],"award-info":[{"award-number":["68036"]}],"id":[{"id":"10.13039\/501100004366","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.humimm.2025.111298","type":"journal-article","created":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T09:41:30Z","timestamp":1743241290000},"page":"111298","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Investigation of immune checkpoint molecules (CTLA-4, PD-1, PD-L1, Tim-3) expressions in preeclampsia: A comparative study of membranous and soluble forms"],"prefix":"10.1016","volume":"86","author":[{"given":"Forough","family":"Parhizkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3139-1035","authenticated-orcid":false,"given":"Najibeh","family":"Shekari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zanyar","family":"HajiEsmailPoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Parsania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Sadegh","family":"Soltani-Zangbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Aghebati-Maleki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0044-5961","authenticated-orcid":false,"given":"Leili","family":"Aghebati-Maleki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humimm.2025.111298_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.jri.2021.103317","article-title":"A new approach to the preeclampsia puzzle; MicroRNA-326 in CD4+ lymphocytes might be as a potential suspect","volume":"145","author":"Zolfaghari","year":"2021","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.humimm.2025.111298_b0010","doi-asserted-by":"crossref","DOI":"10.1111\/aji.13475","article-title":"T lymphocytes and preeclampsia: The potential role of T\u2010cell subsets and related MicroRNAs in the pathogenesis of preeclampsia","volume":"86","author":"Zolfaghari","year":"2021","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.humimm.2025.111298_b0015","doi-asserted-by":"crossref","first-page":"5106","DOI":"10.1002\/jcp.27315","article-title":"The imbalance of Th17\/Treg axis involved in the pathogenesis of preeclampsia","volume":"234","author":"Eghbal-Fard","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.humimm.2025.111298_b0020","article-title":"Preeclampsia-Derived Exosomes Imbalance the Activity of Th17 and Treg in PBMCs from Healthy Pregnant Women","author":"Pourakbari","year":"2022","journal-title":"Reprod. Sci."},{"key":"10.1016\/j.humimm.2025.111298_b0025","doi-asserted-by":"crossref","DOI":"10.1002\/rmb2.12509","article-title":"Sirolimus\u2010and cyclosporine\u2010loaded nanostructured lipid carriers: Development, characterization, and in vitro evaluation in T\u2010cell profiles of patients with a history of recurrent pregnancy loss","volume":"22","author":"Parhizkar","year":"2023","journal-title":"Reprod. Med. Biol."},{"key":"10.1016\/j.humimm.2025.111298_b0030","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41581-022-00670-0","article-title":"The role of immune cells and mediators in preeclampsia","volume":"19","author":"Deer","year":"2023","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.humimm.2025.111298_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40425-018-0449-0","article-title":"Soluble immune checkpoints in cancer: production, function and biological significance","volume":"6","author":"Gu","year":"2018","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.humimm.2025.111298_b0040","doi-asserted-by":"crossref","first-page":"e1160","DOI":"10.1002\/cnr2.1160","article-title":"Soluble immune checkpoint molecules: Serum markers for cancer diagnosis and prognosis","volume":"2","author":"Chakrabarti","year":"2019","journal-title":"Cancer Reports"},{"key":"10.1016\/j.humimm.2025.111298_b0045","article-title":"Immune checkpoints and reproductive immunology: Pioneers in the future therapy of infertility related Disorders?","volume":"99","author":"Khosroshahi","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.humimm.2025.111298_b0050","doi-asserted-by":"crossref","first-page":"846","DOI":"10.3389\/fimmu.2019.00846","article-title":"Immune checkpoint molecules in reproductive immunology","volume":"10","author":"Miko","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2025.111298_b0055","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.humimm.2022.07.004","article-title":"Expression level of immune checkpoint inhibitory factors in preeclampsia","volume":"83","author":"Madadi","year":"2022","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.humimm.2025.111298_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.jri.2023.104125","article-title":"T cell immunity and the etiology and pathogenesis of preeclampsia","volume":"159","author":"Saito","year":"2023","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.humimm.2025.111298_b0065","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3390\/medicina58020157","article-title":"The Role of the Immune Checkpoint Molecules PD-1\/PD-L1 and TIM-3\/Gal-9 in the Pathogenesis of Preeclampsia\u2014A Narrative Review","volume":"58","author":"Mittelberger","year":"2022","journal-title":"Medicina"},{"key":"10.1016\/j.humimm.2025.111298_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113065","article-title":"Composition and effects of seminal plasma in the female reproductive tracts on implantation of human embryos","volume":"151","author":"Ahmadi","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.humimm.2025.111298_b0075","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.imlet.2021.05.008","article-title":"The Impact of New Immunological Therapeutic Strategies on Recurrent Miscarriage and Recurrent Implantation Failure","volume":"236","author":"Parhizkar","year":"2021","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.humimm.2025.111298_b0080","article-title":"Cell therapy in female infertility-related diseases: Emphasis on recurrent miscarriage and repeated implantation failure","volume":"258","author":"Pourakbari","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.humimm.2025.111298_b0085","article-title":"Immunologic aspects of preeclampsia","volume":"4","author":"Boulanger","year":"2024","journal-title":"AJOG Glob Rep"},{"key":"10.1016\/j.humimm.2025.111298_b0090","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/eji.201948382","article-title":"Immune checkpoint molecules in pregnancy: Focus on regulatory T cells","volume":"50","author":"Zhang","year":"2020","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.humimm.2025.111298_b0095","first-page":"1055","article-title":"Co-stimulatory agonists: an insight into the immunotherapy of cancer","volume":"20","author":"Pourakbari","year":"2021","journal-title":"EXCLI J."},{"key":"10.1016\/j.humimm.2025.111298_b0100","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/aji.12069","article-title":"B7 costimulation and intracellular indoleamine\u20102, 3\u2010dioxygenase expression in peripheral blood of healthy pregnant and pre\u2010eclamptic women","volume":"69","author":"Toldi","year":"2013","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.humimm.2025.111298_b0105","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/aji.12410","article-title":"Regulatory T\u2010cell subpopulations in severe or early\u2010onset preeclampsia","volume":"74","author":"Boij","year":"2015","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.humimm.2025.111298_b0110","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jri.2009.01.003","article-title":"Immunoactivation in preeclampsia: V\u03b42+ and regulatory T cells during the inflammatory stage of disease","volume":"80","author":"Miko","year":"2009","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.humimm.2025.111298_b0115","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.fertnstert.2016.06.011","article-title":"Association of functional genetic variants of CTLA4 with reduced serum CTLA4 protein levels and increased risk of idiopathic recurrent miscarriages","volume":"106","author":"Misra","year":"2016","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.humimm.2025.111298_b0120","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1002\/eji.201242529","article-title":"The soluble isoform of CTLA\u20104 as a regulator of T\u2010cell responses","volume":"43","author":"Ward","year":"2013","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.humimm.2025.111298_b0125","first-page":"1","article-title":"The PD-1\/PD-L1 inhibitory pathway is altered in pre-eclampsia and regulates T cell responses in pre-eclamptic rats","volume":"6","author":"Tian","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.humimm.2025.111298_b0130","article-title":"Role of PD1\/PDL1 pathway, and TH17 and treg cells in maternal tolerance to the fetus","volume":"38","author":"Tripathi","year":"2015","journal-title":"Biomed. J."},{"key":"10.1016\/j.humimm.2025.111298_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.jri.2020.103208","article-title":"Immune checkpoint molecules on T cell subsets of pregnancies with preeclampsia and gestational diabetes mellitus","volume":"142","author":"Zhao","year":"2020","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.humimm.2025.111298_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.jri.2023.103949","article-title":"The programmed cell death protein 1 (PD1) and the programmed cell death ligand 1 (PD-L1) are significantly downregulated on macrophages and Hofbauer cells in the placenta of preeclampsia patients","volume":"157","author":"Mittelberger","year":"2023","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.humimm.2025.111298_b0145","doi-asserted-by":"crossref","DOI":"10.1111\/aji.12795","article-title":"Immune checkpoint molecules soluble program death ligand 1 and galectin-9 are increased in pregnancy","volume":"79","author":"Enninga","year":"2018","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.humimm.2025.111298_b0150","doi-asserted-by":"crossref","DOI":"10.1111\/aji.13193","article-title":"Maternal soluble PD\u20101 levels are significantly increased in women with preeclampsia","volume":"83","author":"Gu","year":"2020","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.humimm.2025.111298_b0155","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/ni1271","article-title":"The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity","volume":"6","author":"Zhu","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.humimm.2025.111298_b0160","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aah4323","article-title":"Tim-3 signaling in peripheral NK cells promotes maternal-fetal immune tolerance and alleviates pregnancy loss","volume":"10","author":"Li","year":"2017","journal-title":"Sci. Signal."},{"key":"10.1016\/j.humimm.2025.111298_b0165","doi-asserted-by":"crossref","first-page":"6618","DOI":"10.4049\/jimmunol.0803876","article-title":"Human pregnancy up-regulates Tim-3 in innate immune cells for systemic immunity","volume":"182","author":"Zhao","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.humimm.2025.111298_b0170","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1007\/s43032-021-00675-3","article-title":"Involvement of the Tim-3 pathway in the pathogenesis of pre-eclampsia","volume":"28","author":"Wang","year":"2021","journal-title":"Reprod. Sci."},{"key":"10.1016\/j.humimm.2025.111298_b0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071811","article-title":"Involvement of Galectin-9\/TIM-3 pathway in the systemic inflammatory response in early-onset preeclampsia","volume":"8","author":"Miko","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.humimm.2025.111298_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.jri.2024.104296","article-title":"The expression of TIM-3 and Gal-9 on macrophages and Hofbauer cells in the placenta of preeclampsia patients","volume":"164","author":"Mittelberger","year":"2024","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.humimm.2025.111298_b0185","doi-asserted-by":"crossref","first-page":"4119","DOI":"10.1080\/14767058.2019.1706471","article-title":"Soluble T cell immunoglobulin mucin domain 3 (sTim-3) in maternal sera: a potential contributor to immune regulation during pregnancy","volume":"34","author":"Grossman","year":"2021","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"10.1016\/j.humimm.2025.111298_b0190","first-page":"8812","article-title":"Soluble costimulatory molecule sTim3 regulates the differentiation of Th1 and Th2 in patients with unexplained recurrent spontaneous abortion","volume":"8","author":"Wu","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.humimm.2025.111298_b0195","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/aje\/kwu145","article-title":"Maternal hyperlipidemia and the risk of preeclampsia: a meta-analysis","volume":"180","author":"Spracklen","year":"2014","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.humimm.2025.111298_b0200","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cmet.2019.04.002","article-title":"Cholesterol Induces CD8(+) T Cell Exhaustion in the Tumor Microenvironment","volume":"30","author":"Ma","year":"2019","journal-title":"Cell Metab."}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885925000692?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885925000692?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T04:27:24Z","timestamp":1777696044000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885925000692"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S0198885925000692"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2025.111298","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigation of immune checkpoint molecules (CTLA-4, PD-1, PD-L1, Tim-3) expressions in preeclampsia: A comparative study of membranous and soluble forms","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2025.111298","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111298"}}